Altimmune Promotes Dr. Sybil Tasker to Chief Medical Officer

GAITHERSBURG, Md., May 16, 2017 (GLOBE NEWSWIRE) — Altimmune, Inc. (ALT), a clinical-stage immunotherapeutics company, today announced the promotion of Sybil Tasker, M.D., FACP, FIDSA, to the position of Chief Medical Officer.  Dr. Tasker joined the company in April 2016 as Senior Vice President, Clinical Research and Development, with responsibility for overseeing Altimmune’s clinical research and development programs.